Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1b safety and pharmacodynamic study of PF-07258669 in older adults at risk of malnutrition
jRCT2031250300Phase 1Completed
- Sponsor
- Pfizer
- Start
- Sep 2025
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in Malnutrition comparing PF-07258669 arm with Placebo arm (2 arms). Primary endpoint: Number of Participants With Treatment Emergent Adverse Events. Started Sep 2025; status: completed.
02
Drugs
PF-07258669
03
Conditions
Malnutrition
Beyond the preview
Go deeper on jRCT2031250300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250300.